Evidence map›Paper›PMID 37977293›Full record

ArticleJournal of the American Academy of Dermatology2024

Cutaneous immune-related adverse event burden and effect on immunotherapy: A retrospective review of the experience at a tertiary care immunotherapy center.

Thomas K Le, Elizabeth Schoenberg Newland, Isabelle Brown, Rebecca Goldberg, Yevgeniy R Semenov, Shawn G Kwatra

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the American Academy of Dermatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Thomas K LeDepartment of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Elizabeth Schoenberg NewlandDepartment of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Isabelle BrownDepartment of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Rebecca GoldbergUniversity of Michigan Medical School, Ann Arbor, Michigan.
Yevgeniy R SemenovDepartment of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
Shawn G KwatraDepartment of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland. Electronic address: skwatra1@jhmi.edu.

Funding

Predictive modeling of cutaneous immune checkpoint inhibitor toxicitiesK23AR080791 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI Yevgeniy R Semenov · 2023 to 2026
$704k
NCI NIH HHS L30 CA264747NIAMS NIH HHS K23 AR080791
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

NeoplasmsAntibodies, MonoclonalHumansImmunotherapyRetrospective StudiesTertiary Health CareAntibodies, Monoclonalciraecutaneous immune-related adverse eventsgeneral dermatologyICIimmunotherapyoncology

Identifiers

PMID37977293
PMCPMC10922744

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.